Page last updated: 2024-10-27

furosemide and Bronchiolitis

furosemide has been researched along with Bronchiolitis in 3 studies

Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.

Bronchiolitis: Inflammation of the BRONCHIOLES.

Research Excerpts

ExcerptRelevanceReference
"Bronchiolitis is one of the most common disorders of the lower respiratory tract in infants."6.87A Randomized Controlled Trial of a Single Dose Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis. ( Avarello, J; Bredin, G; Gangadharan, S; Williamson, K, 2018)
"Bronchiolitis is one of the most common disorders of the lower respiratory tract in infants."2.87A Randomized Controlled Trial of a Single Dose Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis. ( Avarello, J; Bredin, G; Gangadharan, S; Williamson, K, 2018)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Williamson, K1
Bredin, G1
Avarello, J1
Gangadharan, S1
Gouin, S1
Ali, S1
Van Bever, HP1
Desager, KN1
Pauwels, JH1
Wojciechowski, M1
Vermeire, PA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis[NCT02469597]Phase 246 participants (Actual)Interventional2013-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Length of Hospital Stay

(NCT02469597)
Timeframe: Participants will be followed for the duration of hospital stay up to 1 week

InterventionDays (Least Squares Mean)
Single Dose of Furosemide3.1
Placebo3.0

Oxygen Saturation

(NCT02469597)
Timeframe: 2 hours after medication adminstration

InterventionPercentage change in oxygen saturation (Least Squares Mean)
Single Dose of Furosemide-0.14
Placebo0.2

Oxygen Saturation

(NCT02469597)
Timeframe: 4 hours after medication adminstration

InterventionPercentage change in oxygen saturation (Least Squares Mean)
Single Dose of Furosemide-0.19
Placebo0.29

Patient Needing Endotracheal Intubation

(NCT02469597)
Timeframe: Within 72 hours of medication administration

Interventionparticipants (Number)
Single Dose of Furosemide0
Placebo0

Respiratory Rate

(NCT02469597)
Timeframe: 2 hours after medication adminstration

InterventionPercentage change in respiratory rate (Least Squares Mean)
Single Dose of Furosemide-3.7
Placebo-1.7

Respiratory Rate

(NCT02469597)
Timeframe: 4 hours after medication adminstration

InterventionPercentage change in respiratory rate (Least Squares Mean)
Single Dose of Furosemide-2.8
Placebo-5.4

Trials

2 trials available for furosemide and Bronchiolitis

ArticleYear
A Randomized Controlled Trial of a Single Dose Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis.
    The Journal of emergency medicine, 2018, Volume: 54, Issue:1

    Topics: Bronchiolitis; Double-Blind Method; Dyspnea; Emergency Service, Hospital; Female; Furosemide; Humans

2018
Aerosolized furosemide in wheezy infants: a negative report.
    Pediatric pulmonology, 1995, Volume: 20, Issue:1

    Topics: Administration, Inhalation; Aerosols; Airway Resistance; Anti-Asthmatic Agents; Bronchiolitis; Doubl

1995

Other Studies

1 other study available for furosemide and Bronchiolitis

ArticleYear
A patient with chaotic atrial tachycardia.
    Pediatric emergency care, 2003, Volume: 19, Issue:2

    Topics: Abnormalities, Multiple; Adenosine; Anti-Asthmatic Agents; Asthma; Bronchiolitis; Combined Modality

2003